921. Deputy Paul Murphy asked the Minister for Health if she agrees that there should be a redress scheme for women who have suffered from mesh injuries. [32729/25]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Medical Aids and Appliances.
252 questions match, newest first.
496. Deputy Seán Canney asked the Minister for Health the reason the HSE makes enteral feeding syringes available free to patients in public nursing homes but not in private nursing homes; and if she will make a statement on the matter. [31357/25]
1441. Deputy Seán Fleming asked the Minister for Health if an electric recliner chair will be provided for a person (details supplied); and if she will make a statement on the matter. [29668/25]
1619. Deputy Pearse Doherty asked the Minister for Health further to Parliamentary Question No. 786 of 20 May 2025, the reason the question has not been answered; when an answer will be forthcoming; and if she will make a statement on the matter. [30549/25]
1621. Deputy Seán Fleming asked the Minister for Health to respond to matters raised in a local newspaper (details supplied); the range and the number of equipment items for children with disabilities that were in storage; the period of time these were in storage; the reason this occurred in view of the vital need for this equipment to have been made available in a timely manner for people who required this equipment…
406. Deputy Michael Cahill asked the Minister for Health the way in which a business can apply for funding (details supplied); and if she will make a statement on the matter. [28101/25]
594. Deputy Erin McGreehan asked the Minister for Health the policies in place to ensure timely access to orthopaedic shoes for individuals who require them for medical reasons; and whether there are plans to streamline the referral process to reduce waiting times for assessments and fittings. [26804/25]
595. Deputy Erin McGreehan asked the Minister for Health whether a review has been conducted on the durability and functionality of bespoke orthopaedic shoes; and what measures exist to improve their quality and address issues related to wear and tear, particularly for individuals limited to one pair per year. [26805/25]
596. Deputy Erin McGreehan asked the Minister for Health whether seasonality is considered when providing orthopaedic shoes, ensuring individuals have appropriate footwear for different weather conditions; and the provisions that exist for individuals with disabilities requiring orthopaedic shoes, including whether European disability status is factored into eligibility criteria. [26806/25]
597. Deputy Erin McGreehan asked the Minister for Health the latest figures on the number of individuals receiving orthopaedic shoe support each year; the average cost per pair; and whether funding or additional support is available for individuals experiencing pain due to delays in receiving new orthopaedic shoes. [26807/25]
656. Deputy Marie Sherlock asked the Minister for Health if she will ensure that CHI is providing clarity, appropriate information and guidance to parents of patients attending CHI in respect of the medium- to long-term use of bladder gastrostomy buttons between 2018 and to date in 2025 and specifically information on protocol and clinical guidelines in use for the insertion of gastrostomy buttons into the bladder, t…
778. Deputy John McGuinness asked the Minister for Health if a special chair can be provided for a person (details supplied). [25096/25]
779. Deputy John McGuinness asked the Minister for Health if a replacement set of special footwear prescribed for a person (details supplied) can be provided immediately. [25127/25]
786. Deputy Pearse Doherty asked the Minister for Health the reason a specialist helmet was turned down for a child (details supplied) by his CDNT; and if she will make a statement on the matter. [25197/25]
794. Deputy Pearse Doherty asked the Minister for Health which local health authorities have a reimbursement scheme offering an ESB rebate in lieu of the excess electricity costs incurred by running a home oxygen generator/machine; and if she will make a statement on the matter. [25236/25]
313. Deputy Seán Crowe asked the Minister for Health the party responsible for the approval of CGM sensors, and if there is an appeals system in place for individuals who are unsuccessful in their application for such a device. [24919/25]
200. Deputy Pádraig Rice asked the Minister for Health if she will direct Children’s Health Ireland to carry out a retrospective communication campaign to formally notify all families of children and young people who have ever received MAGEC rod implants of a field safety notice (FSN) issued by a manufacturer in December 2021, including those patients whose rods have been removed or who have aged out of paediatric ca…
201. Deputy Pádraig Rice asked the Minister for Health if she will provide a detailed breakdown of the total number of children and young people in Ireland who have received MAGEC rod implants, in tabular form; the number that currently have MAGEC rods left to fuse in situ; and the number that have aged out of paediatric care with MAGEC rods still in place; and if she will make a statement on the matter. [24703/25]
202. Deputy Pádraig Rice asked the Minister for Health if she will publish the clinical rationale for the approach of leaving MAGEC rod implants in situ beyond the two-year implantation period recommended by the manufacturer in the December 2021 field safety notice (details supplied); and if she will make a statement on the matter. [24704/25]
203. Deputy Pádraig Rice asked the Minister for Health if Children’s Health Ireland obtained explicit, informed consent from each family prior to a clinical decision being made to leave MAGEC rods in place to fuse in situ; if this consent process included the provision of written information outlining the known increased risks of adverse events associated with prolonged implantation beyond two years as required (deta…
204. Deputy Pádraig Rice asked the Minister for Health if the use of MAGEC rods left to fuse in situ beyond two years in patients under the care of Children’s Health Ireland (CHI), contrary to the manufacturer’s instructions for use, was treated as off-label use under EU Medical Devices Regulation (MDR) 2017/745; if CHI ensured that a documented clinical justification was made; if families received written informatio…
205. Deputy Pádraig Rice asked the Minister for Health if any cases involving the off-label use of MAGEC rods were reviewed by clinical governance structures, ethics committees, or hospital risk management teams within Children’s Health Ireland (CHI) (details supplied); if not, if she will now require CHI to carry out a retrospective audit of these cases to ensure regulatory and ethical compliance; and if she will ma…
206. Deputy Pádraig Rice asked the Minister for Health if Children’s Health Ireland (CHI) routinely monitors blood levels of titanium, cobalt, and chromium in patients with MAGEC rods left to fuse in situ, in light of CHI's own findings (details supplied); if she will publish CHI's clinical policy for the follow-up and monitoring of patients who have aged out of paediatric care with MAGEC rods still in place, includi…
207. Deputy Pádraig Rice asked the Minister for Health the number of vigilance reports or device-related incident notifications which have been submitted by Children’s Health Ireland (CHI) or the HSE to the Health Products Regulatory Authority in relation to MAGEC rods since the implementation of EU Medical Devices Regulation (MDR) 2017/745; if she will publish a breakdown of the nature of adverse events or faults re…
208. Deputy Pádraig Rice asked the Minister for Health the reason MAGEC rods remain unapproved for general use in Ireland and are only accessible under compassionate grounds; if she will publish the clinical and regulatory rationale for this continued restriction, including any safety concerns identified by the Health Products Regulatory Authority or other regulatory bodies; the steps being taken to assess the safety…